Dupilumab Provides Meaningful Clinical Responses in Harlequin Ichthyosis ( ABCA12 ‐ nEDD ): A Report of Two Cases
Pediatric Dermatology · 27.07.2026
DOI: 10.1111/pde.70327 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Dermatology, online erschienen am 27.07.2026. Verfasst von Minu Jose Chiramel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Dermatology, The Hospital for Sick Children, Toronto, Canada. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Harlequin ichthyosis (HI) is a rare epidermal differentiation disorder characterized by thick hyperkeratotic plates, fissuring, and high neonatal morbidity. Long‐term management remains challenging. We report two children with genetically confirmed HI who demonstrated meaningful improvement in pruritus, erythema, scaling, and overall well‐being following dupilumab therapy, suggesting a potential role for IL‐4/IL‐13 blockade as an adjunct or alternative treatment in HI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Dermatology, The Hospital for Sick Children, Toronto, Canada.
- Washington University School of Medicine, St Louis, Missouri, USA.
- Division of Pediatric Dermatology, SSM Health/Cardinal, Glennon Children's Hospital, Departments of Pediatrics and Dermatology, St Louis University School of Medicine, Missouri, USA.
ORCID-Profile: Minu Jose Chiramel, Cynthia Chen, Rebecca Levy
Zitieren
APA
Chiramel, M. J., Chen, C., Siegfried, E., & Levy, R. (2026). Dupilumab Provides Meaningful Clinical Responses in Harlequin Ichthyosis ( ABCA12 ‐ nEDD ): A Report of Two Cases. Pediatric Dermatology. https://doi.org/10.1111/pde.70327
Vancouver
Chiramel MJ, Chen C, Siegfried E, Levy R. Dupilumab Provides Meaningful Clinical Responses in Harlequin Ichthyosis ( ABCA12 ‐ nEDD ): A Report of Two Cases. Pediatric Dermatology. 2026. doi:10.1111/pde.70327
BibTeX
@article{Chiramel2026,
author = {Chiramel, Minu Jose and Chen, Cynthia and Siegfried, Elaine and Levy, Rebecca},
title = {Dupilumab Provides Meaningful Clinical Responses in Harlequin Ichthyosis ( ABCA12 ‐ nEDD ): A Report of Two Cases},
journal = {Pediatric Dermatology},
year = {2026},
doi = {10.1111/pde.70327}
}
EUVIMED